Valuation: Zai Lab Limited

Market Cap 2.77B 2.51B 2.32B 2.09B 3.94B 261B 4.08B 27.85B 11.04B 139B 10.38B 10.16B 442B P/E 2026 *
-13.2x
P/E 2027 * -11.5x
Enterprise Value 2.13B 1.93B 1.78B 1.61B 3.03B 201B 3.14B 21.42B 8.49B 107B 7.98B 7.81B 340B EV / Sales 2026 *
4.84x
EV / Sales 2027 * 4.26x
Free-Float
93.88%
Yield 2026 *
-
Yield 2027 * -

Last Transcript: Zai Lab Limited

1 day-5.53%
1 week-3.45%
Current month+11.46%
1 month+4.64%
3 months-5.02%
6 months+19.48%
Current year+39.46%
1 week 23.43
Extreme 23.43
27.19
1 month 21.42
Extreme 21.4176
29.02
Current year 15.96
Extreme 15.96
29.02
1 year 15.96
Extreme 15.96
29.02
3 years 13.48
Extreme 13.48
44.34
5 years 13.48
Extreme 13.48
91.84
10 years 13.48
Extreme 13.48
193.54
Manager TitleAgeSince
Chief Executive Officer 61 01/04/2014
Director of Finance/CFO 58 07/07/2023
President 62 01/12/2022
Director TitleAgeSince
Chairman 61 01/04/2014
Director/Board Member 83 01/01/2017
Director/Board Member 75 01/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
1/10/26 Exercice

Chief Financial Officer

2,155 0.0002%
19/8/26 Sell

Chief Financial Officer

-260 0.0000%
14/8/26 Exercice

Chief Financial Officer

2,927 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-5.53%-3.45%+13.10%-11.13% 2.77B
+1.14%+6.61%+40.79%+145.27% 1,286B
+0.79%+3.45%+45.84%+92.04% 688B
+0.20%+1.28%+26.97%+114.41% 521B
+0.58%+1.32%+41.50%+71.59% 386B
+0.55%+0.70%+59.02%+45.79% 364B
+1.03%+1.27%+27.77%+62.39% 302B
+0.43%-0.47%+3.00%+37.71% 287B
-0.30%+1.14%+38.29%+70.56% 252B
+0.08%+0.71%+34.44%+123.99% 208B
Average -0.11%+1.52%+33.07%+75.26% 430B
Weighted average by Cap. +0.67%+3.25%+37.62%+99.44%

Financials

2026 *2027 *
Net sales 439M 398M 368M 332M 626M 41.41B 648M 4.42B 1.75B 22.12B 1.65B 1.61B 70.21B 538M 487M 451M 407M 766M 50.68B 793M 5.41B 2.15B 27.07B 2.02B 1.97B 85.94B
Net income -213M -193M -179M -161M -304M -20.13B -315M -2.15B -852M -10.75B -801M -784M -34.13B -218M -198M -183M -165M -311M -20.57B -322M -2.2B -871M -10.99B -819M -801M -34.88B
Net Debt -639M -579M -535M -483M -910M -60.22B -942M -6.43B -2.55B -32.17B -2.4B -2.35B -102B -474M -429M -397M -358M -675M -44.68B -699M -4.77B -1.89B -23.87B -1.78B -1.74B -75.76B
Projected Income Statement - Annual - Zai Lab Limited
Logo Zai Lab Limited
Zai Lab Ltd is a holding company primarily engaged in biopharmaceutical business. The Company is focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. The Company has a series of patented drug candidates from the discovery stage to the late clinical project, including ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others. The Company conducts its businesses within domestic and overseas markets.
Employees
1,784
Date Price Change Volume
13/11/26 US$24.60 -5.53% 1,224,364
12/11/26 US$26.04 -1.44% 859,415
11/11/26 US$26.42 -0.04% 920,477
10/11/26 US$26.43 -1.60% 1,531,721
09/11/26 US$26.86 +5.42% 2,102,592
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
MarketScreener Ratings - Zai Lab Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
24.60USD
Average target price
34.12USD
Spread / Average Target
+38.72%
  1. Stock Market
  2. Stocks
  3. ZLAB Stock